Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MilliporeSigma Launches LANEXO | Contract Pharma

What are you searching for?

Sign in
Breaking News

MilliporeSigma Launches LANEXO

Digital laboratory informatics solution aims to reduce time in labs and improve data quality and traceability

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma has launched its LANEXO Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to reduce time in labs and improve data quality and traceability.

According to the company, it is the first to offer radio-frequency identification (RFID) labels which auto-register open dates and calculate expiry dates. Through this digital data capture, the LANEXO System documents lab reagent data in real time. Digitalized inventory, expiration and storage monitoring aims to reduce human error and safety risks and improve the reliability and traceability of compliance documentation. Ultimately, each reagent, including in-house preparations, can be instantly matched to a full audit report.   

The cloud-based LANEXO System can be easily set up and rapidly integrated into existing lab workflows. It includes mobile (Android) and web applications and is designed for use in highly regulated analytical and research labs in pharmaceutical, quality assurance / quality control and industrial testing markets.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics